Trial Profile
A randomised, multicentre, double-blind, placebo controlled study of the symptomatic efficacy and safety of diacerein 100 mg/day in patients with painful hand osteoarthritis. A 16-week, prospective study with a 12-week treatment-free follow-up
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Diacerein (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- 19 Jul 2011 New trial record